BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 15236397)

  • 1. Human T-lymphotropic virus type II and neurological disease.
    Araujo A; Hall WW
    Ann Neurol; 2004 Jul; 56(1):10-9. PubMed ID: 15236397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology and disease outcomes of human T-lymphotropic virus type II.
    Roucoux DF; Murphy EL
    AIDS Rev; 2004; 6(3):144-54. PubMed ID: 15595431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-I/II prevalence in different geographic locations.
    Vrielink H; Reesink HW
    Transfus Med Rev; 2004 Jan; 18(1):46-57. PubMed ID: 14689377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological aspects of HIV/human T lymphotropic virus coinfection.
    Tulius Silva M; de Melo Espíndola O; Bezerra Leite AC; Araújo A
    AIDS Rev; 2009; 11(2):71-8. PubMed ID: 19529747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
    Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
    Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].
    Christiansen CB
    Ugeskr Laeger; 1994 Dec; 156(51):7663-7. PubMed ID: 7839528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of HTLV-I and HTLV-II infection in the AIDS epidemic.
    Pierik LT; Murphy EL
    AIDS Clin Rev; 1991; ():39-57. PubMed ID: 1868010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implications.
    Amano M; Setoyama M; Grant A; Kerdel FA
    Int J Dermatol; 2011 Aug; 50(8):915-20. PubMed ID: 21781059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
    Shuh M; Beilke M
    Microsc Res Tech; 2005 Nov; 68(3-4):176-96. PubMed ID: 16276549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A possible case of myelopathy/tropical spastic paraparesis in an Argentinian woman with human T lymphocyte virus type II.
    Biglione MM; Pizarro M; Salomón HE; Berría MI
    Clin Infect Dis; 2003 Aug; 37(3):456-8. PubMed ID: 12884173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Jacobson S; Lehky T; Nishimura M; Robinson S; McFarlin DE; Dhib-Jalbut S
    Ann Neurol; 1993 Apr; 33(4):392-6. PubMed ID: 8489210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
    Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
    Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
    Brites C; Sampalo J; Oliveira A
    AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I.
    Yao K; Hisada M; Maloney E; Yamano Y; Hanchard B; Wilks R; Rios M; Jacobson S
    J Infect Dis; 2006 Feb; 193(3):427-37. PubMed ID: 16388491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
    Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
    Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and biological epidemiology of onco-retroviral HTLV-I and II infections].
    De Thé G
    Bull Acad Natl Med; 1991; 175(6):861-9; discussion 869-70. PubMed ID: 1742624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.